Peter Purgathofer looked over “Advanced Nanovaccines for Cancer Immunotherapy” by Nanasaheb Thorat, published in March by Springer Nature. On page 25, he found why we pay Springer the big bucks: [h…
  • Lumidaub@feddit.orgEnglish
    8·
    15 days ago

    Just fyi for Germans: be aware that, contrary to what might seem intuitive, this is not Axel Springer, they just share a name and a stance on honesty.